2012
DOI: 10.1152/ajprenal.00617.2011
|View full text |Cite
|
Sign up to set email alerts
|

Role of mitochondria in paricalcitol-mediated cytoprotection during obstructive nephropathy

Abstract: Vitamin D slows the progression of chronic kidney disease. Furthermore, activators of vitamin D receptors (VDR) have suppressant effects on the renin-angiotensin system, as well as anti-inflammatory and antifibrotic actions. This study aimed to evaluate the cytoprotective effects of paricalcitol, a VDR activator, at the mitochondrial level using an obstructive nephropathy model [unilateral ureteral obstruction (UUO)]. Rats subjected to UUO and controls were treated daily with vehicle or paricalcitol. The contr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
47
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 50 publications
(58 citation statements)
references
References 40 publications
5
47
0
Order By: Relevance
“…Further evidence for RAS/VDR signaling interactions was provided by our study in rats subjected to obstructive nephropathy (a model of RAS upregulation) and treated with the VDR activator paricalcitol, where VDR activation attenuated renal fibrosis, apoptosis, and mitochondrial injury, accompanied by reduction of mitochondrial AT 1 R mRNA contents and VDR upregulation (147). In SHR, the same renal protective effects were brought about by 4 mo paricalcitol, enalapril, or combined paricalcitol-enalapril treatments.…”
Section: The Klotho-vitamin D-ras Connectionsupporting
confidence: 51%
“…Further evidence for RAS/VDR signaling interactions was provided by our study in rats subjected to obstructive nephropathy (a model of RAS upregulation) and treated with the VDR activator paricalcitol, where VDR activation attenuated renal fibrosis, apoptosis, and mitochondrial injury, accompanied by reduction of mitochondrial AT 1 R mRNA contents and VDR upregulation (147). In SHR, the same renal protective effects were brought about by 4 mo paricalcitol, enalapril, or combined paricalcitol-enalapril treatments.…”
Section: The Klotho-vitamin D-ras Connectionsupporting
confidence: 51%
“…In this context, we show that mitochondrial injury linked to AT 1 /VDR uncoupling was improved when paricalcitol, enalapril, or, better still, the combination of both was used. This finding is feasible taking into consideration recent contributions that reported the identification and characterization of a functional mitochondrial RAS (Abadir et al 2011), the mitochondrial localization of VDR (García et al 2012 andSilvagno et al 2010), and ultrastructural mitochondrial improvement as a consequence of recovery in mitochondrial VDR expression linked to poor AT 1 and NADPH oxidase activity during obstructive nephropathy. Moreover, a ligand-independent mitochondrial import of VDR through the permeability transition pore (PTP) was reported (Silvagno et al 2013); and since functional and structural changes in mitochondria are caused by the opening of the mitochondrial PTP and by the mitochondrial generation of ROS, this finding open new perspectives on PTP function as transporter and on VDR role in mitochondria.…”
Section: Discussionmentioning
confidence: 72%
“…A standard point counting method (Hruska et al 2000;Morrissey et al 2002) was used to quantitate the fibrosis of the renal interstitium. The fibrosis of the renal cortical interstitium was determined as previously reported (García et al 2012), and the results were expressed as a percentage of the measured area.…”
Section: Morphometric Evaluation Of Interstitial Fibrosismentioning
confidence: 99%
See 2 more Smart Citations